CLINICAL AND MICROBIOLOGICAL EFFICACY OF THE TREATMENT OF DIFFICULT TEMPORARY TEETH ERUPTION IN CHILDREN

Abstract

Eruption of temporary teeth in children is accompanied by a wide range of undesirable local and general manifestations and the changes in the oral cavity microbiocenosis. The purpose of this research was to evaluate the clinical and microbiological effectiveness of the use of topical drugs in the syndrome of difficult temporary teeth eruption in children. Materials and methods used: 120 children aged 5 months to 2 years old randomly distributed into 3 groups of 40 with difficulties in the eruption of temporary teeth. For the studied period of eight days all of the children have been receiving drugs to relieve unwanted symptoms in case of difficult eruption of temporary teeth: Dantinorm Baby by BOIRON, France, CALGEL Teething Gel by GlaxoSmithKline Pharmaceuticals, UK/Poland, and Viburgel by Biologische Heilmittel Heel GmbH, Germany. The dental status was carried out according to the PMA index; the state of the oral cavity microbiocenosis was assessed as well. Results: the gums’ PMA index after the course of Dantinorm Baby corresponded to mild degree of gingivitis, whilst both CALGEL Teething Gel and Viburgel had corresponded to the moderate degree. Against the background of the drug use the ratio between cariogenic and periodontopathogenic groups of the microbiota shifted towards the predominance of stabilizing species such as S. salivarius, S. sanguis, Corynebacterium spp. and Veillonella parvula in the group 1 versus the use of the drugs in the groups 2 and 3. Conclusions: clinical efficacy of the Dantinorm Baby drug in difficult temporary teeth eruption was higher, was accompanied by stabilization of oral microbiocenosis in children.